Latest filing published 03 Feb 2026 for HERON THERAPEUTICS, INC. /DE/.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Sharmila Dissanaike: trading record in brief
This profile gathers the share dealings of Sharmila Dissanaike in Heron Therapeutics, Inc. /DE/, where the filings describe the role as board member. In total, 6 filings cover trades dated from 22 December 2021 to 30 January 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 February 2026, the filings show a share grant in Heron Therapeutics, Inc. /DE/. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sharmila Dissanaike
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 53,960 shares0Common StockSEC:0001193125-26-034626:0
- 17,950 shares0Common StockSEC:0000950170-25-013770:0
- 17,950 shares0Common StockSEC:0000950170-25-012107:0
- 13,948 shares0Common StockSEC:0001209191-24-001978:0
- 38,580 shares0Common StockSEC:0001209191-22-062187:0
- 10,452 shares0Common StockSEC:0001209191-21-071168:0
6 of 6 declarations
